INSULET CORP

INSULET CORP Share · US45784P1012 · PODD · A0MQX8 (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of INSULET CORP
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
35
12
3
0
No Price
01.05.2026 21:07
Current Prices from INSULET CORP
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
PODD
USD
01.05.2026 21:07
171,61 USD
-0,53 USD
-0,31 %
IEXG: IEX
IEX
PODD
USD
01.05.2026 19:59
175,06 USD
2,92 USD
+1,70 %
XDUS: Düsseldorf
Düsseldorf
ICRSDL12.DUSB
EUR
30.04.2026 14:00
141,90 EUR
4,80 EUR
+3,50 %
XDQU: Quotrix
Quotrix
ICRSDL12.DUSD
EUR
30.04.2026 05:27
137,10 EUR
-
ESG Risk Rating
B- Good
Share Float & Liquidity
Free Float 101,21 %
Shares Float 70,1 M
Shares Outstanding 69,26 M
Invested Funds

The following funds have invested in INSULET CORP:

Fund
iShares US Medical Devices UCITS ETF USD (Acc)
Vol. in million
623,41
Percentage (%)
1,12 %
Fund
iShares MSCI USA SRI UCITS ETF EUR Hedged (Dist)
Vol. in million
905,68
Percentage (%)
0,26 %
Fund
iShares MSCI USA SRI UCITS ETF USD (Dist)
Vol. in million
1.067,69
Percentage (%)
0,26 %
Fund
iShares MSCI World Health Care Sector UCITS ETF USD (Dist)
Vol. in million
925,44
Percentage (%)
0,25 %
Fund
iShares MSCI USA ESG Enhanced UCITS ETF EUR Hedged (Acc)
Vol. in million
0,51
Percentage (%)
0,15 %
Company Profile for INSULET CORP Share
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Company Data

Name INSULET CORP
Company Insulet Corporation
Symbol PODD
Website https://www.insulet.com
Primary Exchange XNAS NASDAQ
WKN A0MQX8
ISIN US45784P1012
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Ashley A. McEvoy
Market Capitalization 12 Mrd.
Country United States of America
Currency USD
Employees 3,9 T
Address 100 Nagog Park, 01720 Acton
IPO Date 2007-05-15

Ticker Symbols

Name Symbol
Düsseldorf ICRSDL12.DUSB
Frankfurt GOV.F
NASDAQ PODD
Quotrix ICRSDL12.DUSD
More Shares
Investors who hold INSULET CORP also have the following shares in their portfolio:
ADVANCED MICRO DEVICES INC
ADVANCED MICRO DEVICES INC Share
AMGEN INC
AMGEN INC Share
ANALOG DEVICES INC
ANALOG DEVICES INC Share
APPLIED MATERIALS INC
APPLIED MATERIALS INC Share
AUTODESK INC
AUTODESK INC Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
CORTEX
CORTEX Crypto
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
EXELON CORP 16/46
EXELON CORP 16/46 Bond
MONSTER BEVERAGE CORP
MONSTER BEVERAGE CORP Share
STARBUCKS CORP
STARBUCKS CORP Share
Ultimate Franchise Systems Inc.
Ultimate Franchise Systems Inc. Share
UNIEUROKAPITAL CORPNET A
UNIEUROKAPITAL CORPNET A Fund
VERISK ANALYTICS INC
VERISK ANALYTICS INC Share